Atom Investors LP Repligen Corp Transaction History

Atom Investors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $220,194 - $307,169	-1,487 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$122.51 - $158.27 $182,172 - $235,347	1,487 New	1,487 $219,000
Q1 2019 May 15, 2019	SELL	$49.45 - $62.8 $744,766 - $945,830	-15,061 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$48.26 - $68.88 $726,843 - $1.04 Million	15,061 New	15,061 $794,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.